STAT Plus: After a bespoke therapy rescues a young girl, the FDA considers advance of individualized treatments
COURTESY JULIA VITARELLO
The director of the FDA's Center for Drug Evaluation and Research says regulators are trying to determine how best to advance “N of 1” treatments.
.png)
No hay comentarios:
Publicar un comentario